Vigil Neuroscience, Inc. (VIGL) Dividend History

Company News

• $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger – PRA, AXL, SWTX and VIGL

  Monteverde & Associates PC, a top 50 class action law firm, is investigating the proposed mergers of ProAssurance Corporation, American Axle & Manufacturing Holdings, SpringWorks Therapeutics, and Vigil Neuroscience. The firm is encouraging shareholders to take action and learn more about the proposed transactions.

  GlobeNewswire Inc.

  Featured Companies: AXL PRA SWTX
• $HAREHOLDER NOTICE: The M&A Class Action Firm Continues To Investigate The Merger - PRA, AXL, SWTX and VIGL

  The M&A Class Action Firm is investigating the proposed mergers of ProAssurance Corporation, American Axle & Manufacturing Holdings, SpringWorks Therapeutics, and Vigil Neuroscience.

  Benzinga

  Featured Companies: AXL PRA SWTX
• SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, VIGL, STRR on Behalf of Shareholders

  Halper Sadeh LLC, an investor rights law firm, is investigating several companies for potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to proposed mergers and acquisitions.

  GlobeNewswire Inc.

  Featured Companies: SGMA STRR STRRP TXNM
• $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

  Class Action Attorney Juan Monteverde is investigating the proposed merger of Star Equity Holdings, Inc. (NASDAQ: STRR) with Hudson Globl, Inc. and the proposed acquisition of Vigil Neuroscience, Inc. (NASDAQ: VIGL).

  GlobeNewswire Inc.

  Featured Companies: STRR STRRP
• $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)

  Class action attorney Juan Monteverde is investigating the proposed merger between Vigil Neuroscience, Inc. and Sanofi, a French company, where Sanofi will acquire Vigil for $8 per share in cash plus a potential $2 per share contingent value right.

  Benzinga